Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,361 | -31,280 | -60,644 | -36,368 | -11,798 |
| Depreciation Amortization | 15,416 | 7,129 | 28,680 | 21,101 | 13,979 |
| Accounts receivable | -30,839 | 1,279 | -10,580 | -12,123 | -1,502 |
| Accounts payable and accrued liabilities | 1,991 | -2,646 | 66 | -2,293 | -1,833 |
| Other Working Capital | -51,968 | -12,681 | 86,025 | 86,578 | 6,113 |
| Other Operating Activity | 42,418 | 5,871 | 19,946 | 21,090 | 7,205 |
| Operating Cash Flow | $-66,343 | $-32,328 | $63,493 | $77,985 | $12,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,419 | 26,103 | -252,792 | -168,732 | -47,324 |
| PPE Investments | -3,100 | -1,403 | -1,552 | -1,113 | -591 |
| Sale Of Investment | 737 | 454 | 2,428 | 2,110 | 1,938 |
| Purchase Sale Intangibles | -1,791 | -333 | -3,810 | -2,721 | -1,171 |
| Other Investing Activity | -1,791 | -333 | -3,810 | -2,721 | -1,171 |
| Investing Cash Flow | $-7,573 | $24,821 | $-255,726 | $-170,456 | $-47,148 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,392 | -2,691 | -11,039 | -8,306 | -5,573 |
| Common Stock Issued | 13,416 | 12,003 | 236,250 | 230,190 | 210,102 |
| Other Financing Activity | 0 | 0 | 2,513 | 2,513 | 2,513 |
| Financing Cash Flow | $8,024 | $9,312 | $227,724 | $224,397 | $207,042 |
| Beginning Cash Position | 159,973 | 159,973 | 124,482 | 124,482 | 124,482 |
| End Cash Position | 94,081 | 161,778 | 159,973 | 256,408 | 296,540 |
| Net Cash Flow | $-65,892 | $1,805 | $35,491 | $131,926 | $172,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,343 | -32,328 | 63,493 | 77,985 | 12,164 |
| Capital Expenditure | -3,100 | -1,403 | -1,552 | -1,113 | -591 |
| Free Cash Flow | -69,443 | -33,731 | 61,941 | 76,872 | 11,573 |